Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis

Open access
Peferoen, Laura A. N., Lamers, Floris, Lodder, Lenthe N. R., Gerritsen, Wouter H., Huitinga, Inge, Melief, Jeroen, Giovannoni, Gavin, Meier, Ute, Hintzen, Rogier Q., Verjans, Georges M. G. M., van Nierop, Gijsbert P., Vos, Wim, Peferoen-Baert, Regina M. B., Middeldorp, Jaap M., van der Valk, Paul, Amor, Sandra · 2010 · Brain

Abstract

Sir, Although recent studies have demonstrated a clear association of Epstein-Barr virus (EBV) infection with multiple sclerosis (Zaadstra et al., 2008; Lünemann and Münz, 2009; Salvetti et al., 2009), there has been much debate if and where the virus acts in the pathogenic cascade of multiple sclerosis and whether the virus needs to gain entry to the central nervous system (CNS). A recent study reported in Brain by Willis et al. (2009) showed that there is little evidence for the presence of EBV in the central nervous system of people with multiple sclerosis. These findings contrast greatly with the studies by Serafini et al. (2007) that have described abundant EBV positive cells in multiple sclerosis, and the presence of ectopic B cell follicles enriched with EBV infected cells in some patients. Willis and co-workers used a variety of validated methods to determine the presence of EBV in the CNS of patients with B cell infiltrates within the meninges and parenchyma. The paper described two crucial observations. Unlike Serafini et al. (2007), Willis et al. did not find the presence of EBV to be a characteristic feature of multiple sclerosis (aptly the title of the paper). Second, ectopic follicles, suggested by Serafini et al. to harbour EBV infected B cells, were not observed, despite scrutiny of meningeal tissues where these follicles should have been present. Clearly, the issue of whether EBV is indeed present in the CNS is crucial not only to determine the impact of the virus on the disease in the CNS, but also for diagnostic pathology in general. The studies reveal the vagaries of pathological detection methods for infectious agents such as EBV. Care in the practice and interpretation of such methodologies are of course key for correct diagnosis and proving pathogenic involvement and ultimately, to ensure correct treatment of patients with multiple sclerosis. In our laboratory (VUMC), an in situ hybridization technique is widely used to detect EBV encoded RNA in various pathological specimens (Middeldorp et al., 2003) and our degree of positive samples does not differ significantly from that reported in literature. EBV encoded RNA is generally localized to the nucleus. This is the case for all EBV-associated malignancies, including Hodgkin's disease, Burkitt's lymphoma and brain lymphomas. EBV encoded RNA detected in the cytoplasm of cells in interphase, or in plasma cells or eosinophils are considered false positives, due to the application of over-sensitive methods (Gulley and Tang, 2008). As a consequence of the report by Serafini et al. (2007), many laboratories have been keen to examine whether their detection methods allowed them to detect EBV in the CNS of people with multiple sclerosis. Together with many collaborators in the Netherlands and UK, we have screened 632 CNS specimens from 94 multiple sclerosis patients collected by the Netherlands Brain Bank. All samples were carefully processed with short fixation times to optimize RNA quality and subsequently subjected to EBV encoded RNA staining using an optimized EBV encoded RNA PNA-based (Dako, Denmark) protocol. In addition, 12 blocks of tissue samples from 12 patients documented in the Serafini et al. (2007) paper were obtained from the Multiple Sclerosis Society Brain Bank in London, UK, and taken from the very same tissue blocks used in that study. All the UK samples on which we performed the EBV encoded RNA technique were negative. We also performed immunohistochemistry for EBV lytic (BZLF1, BMRF1, BFRF3 and BLLF1) and latent (LMP1) proteins. One of us (J.M.M.) has produced many EBV antibodies including those used in the Serafini et al. paper, and has developed sensitive methods for EBV detection in pathological tissues. All tissue blocks available were screened for ectopic lymphoid follicles and the presence of infiltrates, B cells and plasma cells. In the majority of tissue samples, meningeal tissues were present. Given the claim that ectopic follicles are associated with early onset multiple sclerosis and death in the secondary progressive phase (Serafini et al., 2007), we specially studied such a group of 11 patients (76 blocks), who all died before the age of 50. Ectopic B-cell follicles, as defined by the presence of CXCL13 or podoplanin (Marsee et al., 2009), were not observed in this cohort. Likewise, we examined 60 tissue blocks from 16 patients exhibiting prominent B cell infiltrates (Table 1). Again, however, ectopic follicles or follicular-like structures were not observed. Two of the 50 blocks containing B cells in perivascular infiltrates show only diffuse staining for CXCL-13. Extent of CNS B-cell infiltration in the VUMC multiple sclerosis cohort a Multiple sclerosis tissue blocks were screened from 94 multiple sclerosis cases (632 blocks) for the presence of B cells. In total, 60 tissue blocks from the 16 B cell-rich cases were screened. The extent of B cell infiltration was defined subjectively as the number of perivasc

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awp296

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Selective association of multiple sclerosis with infectious mononucleosis

    Zaadstra, B., Chorus, A., van Buuren, S., Kalsbeek, H., & van Noort, J. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084265 · Cited by 41 · cited 1×

    “Nevertheless the debate on the role that EBV plays in the pathogenesis of multiple sclerosis should continue since the epidemiological data are compelling (Ascherio and Munger, 2007; Zaadstra et al., 2008); however, we may wish to focus on mechanisms explaining how EBV contributes to the early stages of multiple scler…”
    Background

Cited by

See all 158

Metadata

Authors
Peferoen, L. A. N., Lamers, F., Lodder, L. N. R., Gerritsen, W. H., Huitinga, I., Melief, J., Giovannoni, G., Meier, U., Hintzen, R. Q., Verjans, G. M. G. M., van Nierop, G. P., Vos, W., Peferoen-Baert, R. M. B., Middeldorp, J. M., van der Valk, P., & Amor, S.
Venue
Brain
Published
2009-11-16
Volume
133
Issue
5
Pages
e137-e137
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2114832666
Cited by
158
References
1
FWCI
11.78
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.